Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
about
Serologic markers in inflammatory bowel disease: tools for better diagnosis and disease stratificationAntibody markers in the diagnosis of inflammatory bowel diseaseHost-microbiome interaction in Crohn's disease: A familiar or familial issue?Association of levels of antibodies from patients with inflammatory bowel disease with extracellular proteins of food and probiotic bacteria.Serological markers (anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic antibodies) in inflammatory bowel disease: diagnostic utility and phenotypic correlation.Current and future role of biomarkers in Crohn's disease risk assessment and treatment.Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases.Immunogenetic phenotypes in inflammatory bowel disease.New biomarkers of Crohn's disease: serum biomarkers and development of diagnostic tools.Serological antibodies in inflammatory bowel disease: a systematic review.Diagnostic Value of ASCA and Atypical p-ANCA in Differential Diagnosis of Inflammatory Bowel Disease.Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.Multilocus sequence typing reveals intrafamilial transmission and microevolutions of Candida albicans isolates from the human digestive tract.Serologic investigations in children with inflammatory bowel disease and food allergy.Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Serum antibodies associated with complex inflammatory bowel disease.Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels.
P2860
Q22241487-060B678E-8DF8-4BAB-B93B-F499E8135398Q26774452-FD5B55AB-BA8B-4724-A326-A3E4B66DFE6FQ26776158-09C97085-089B-4C56-9086-D3F0534DEF07Q33787065-1AA7E38B-088B-4011-8540-3957F2EDEAA6Q34143593-564CEA11-A079-4CC4-BB7D-DF8C1DD3C4F5Q35095265-1672782E-3F18-496A-BF57-12EB8C0E9557Q35748693-EE9F412C-36E4-473F-B520-06DDC01FE4C0Q36506455-09643BFD-CFF3-421C-B481-FF3CF0709842Q37206175-90394DC5-624F-4D2E-8420-B47B6D445BD9Q37954231-8F000DE9-DC68-40C6-8D9A-C977F9281328Q38806076-45302C14-91CD-4EB1-B9E0-D30073D3953BQ39040664-808DB5E2-5AD4-49FB-8C6F-090C37AB863AQ42054944-6416E5C6-F9D4-4950-B144-14AA2CC38550Q42949646-C833744E-7293-4B35-B1A7-DFEB9875F724Q43886944-89F894CC-7404-4940-8B2B-04DF300404C8Q47661706-498A1E48-BCC3-404C-984E-7FB67C0A0C42Q50965440-D3444BA1-7662-416E-BA3E-224AC6D7CC1AQ54360569-B1FAD7D3-BE72-4130-8C09-6088DCDC5E60
P2860
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@ast
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@en
type
label
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@ast
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@en
prefLabel
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@ast
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@en
P2093
P2860
P50
P356
P1433
P1476
Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease
@en
P2093
P2860
P304
P356
10.1136/GUT.2005.066860
P407
P577
2005-04-29T00:00:00Z